A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution
The American Journal of Managed Care · 2023
DOI: 10.37765/ajmc.2023.89464 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of Managed Care, 2023. Verfasst von John D Sheppard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Eye Consultants, 241 Corporate Boulevard. Norfolk, VA 23502. mmarino@cvphealth.com. Hauptthemen laut MEDLINE: Dry Eye Syndromes. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Virginia Eye Consultants, 241 Corporate Boulevard. Norfolk, VA 23502. mmarino@cvphealth.com.
Zitieren
APA
Sheppard, J. D., Evans, D. G., & Protzko, E. E. (2023). A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2023.89464
Vancouver
Sheppard JD, Evans DG, Protzko EE. A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution. The American Journal of Managed Care. 2023. doi:10.37765/ajmc.2023.89464
BibTeX
@article{Sheppard2023,
author = {Sheppard, John D and Evans, David G and Protzko, Eugene E},
title = {A Review of the First Anti-Evaporative Prescription Treatment for Dry Eye Disease: Perfluorohexyloctane Ophthalmic Solution},
journal = {The American Journal of Managed Care},
year = {2023},
doi = {10.37765/ajmc.2023.89464}
}
EUVIMED